Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

NCT06257693 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: enzalutamide

Sponsor

Alessa Therapeutics Inc.

Collaborators

[object Object]